TWN INTELLECTUAL PROPERTY RIGHTS SERIES

An Update on Intellectual Property Claims Related to Global Pandemic Influenza Preparedness (No. 15)
by Edward Hammond


Intellectual Property and Technology Transfer Issues in the Context of Climate Change (No. 14)
by Sangeeta Shashikant & Martin Khor


The IMPACT Counterfeit Taskforce, Intellectual Property Rights Enforcement and Seizure of Medicines (No. 13)
by Sangeeta Shashikant


Some Intellectual Property Issues Related to H5N1 Influenza Viruses, Research and Vaccines (No. 12)
by Edward Hammond


The Substantive Patent Law Treaty: The Dangers of Global Patent Policy Harmonization (No. 11)
by Sangeeta Shashikant


Patents, Compulsory Licences and Access to Medicines: Some Recent Experiences (No. 10)
by Martin Khor


Malaysia’s Experience in Increasing Access to Antiretroviral Drugs: Exercising the ‘Government Use’ Option (No. 9)
by Chee Yoke Ling


Imports by and Exports to Countries with Insufficient or No Manufacturing Capacities in the Pharmaceutical Sector (No. 8)
by TWN


Intellectual Property, Competition and Development (No. 7)
by Martin Khor


Compulsory Licensing: Models for State Practices in Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord (No. 6)
by James Love


Biodiversity, Traditional Knowledge and Rights of Indigenous Peoples (No. 5)
by Victoria Tauli-Corpuz


Patents and Development: Lesson Learnt from the Economic History of Switzerland (No. 4)
by Richard Gerster


Intellectual Property Rights and Economic Development – Historical Lessons and Emerging Issues (No. 3)
by Ha-Joon Chang


TRIPS, Drugs and Public Health: Issues and Proposals (No. 2)
by Third World Network


Rethinking IPRs and the TRIPS Agreement (No. 1)
by Martin Khor